Expert Review of Clinical Immunology

Article	Citations
Full consideration of the pollen exposure effect in clinical trial design for pollen-induced allergic rhinitis	114
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?	84
Pepsin, trypsin, and MUC5B are independent risk factors for hearing impairment in patients with laryngopharyngeal reflux-related chronic secretory otitis media	67
The therapeutic effect of mRNA vaccines in glioma: a comprehensive review	64
Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype	58
Immunobiology and treatment of cutaneous T-cell lymphoma	55
Bimekizumab for the treatment of psoriatic arthritis	55
How could our genetics impact COVID-19 vaccine response?	42
Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations	40
Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and multiple sclerosis	39
CAR-T cell immunotherapy of malignant melanoma	33
A prospective single-arm study on the efficacy and safety of short-course oral corticosteroids followed by topical corticosteroids in patients with severe chronic rhinosinusitis with nasal polyps	32
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations	31
A critical review of dupilumab for adult patients with prurigo nodularis	31
Bradford Hill and breast implant illness: no evidence for causal association with breast implants	30
Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives	30
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease	29
The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren’s syndrome related dry eye	29
IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma	28
Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge	27
Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud’s phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study	27
Food immunotherapy: current status and future needs	27
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment	27
Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review	27
Differential risk of autoimmune disorders in non-traumatic osteonecrosis: clue to pathogenesis	26

Drug development in systemic sclerosis: novel therapeutics to watch	26
How to and should we target EBV in MS?	23
Impact of anti-PD1 immunotherapy and circulating tumor cells on progression-free survival in surgical pancreatic adenocarcinoma: a retrospective cohort study	22
Neurological adverse effects of chimeric antigen receptor T-cell therapy	22
Inflammatory bowel disease and primary sclerosing cholangitis: immunological links and clinical outlook	22
Rare forms of inflammatory myopathies – part I, generalized forms	21
Current treatment options and long-term outcomes in patients with eosinophilic esophagitis	21
Transcriptional regulation of B cell class-switch recombination: the role in development of noninfectious complications	21
Durability and long-term outcomes of biologic therapies in psoriasis	20
Gut immune homeostasis: the immunomodulatory role of Bacillus clausii, from basic to clinical evidence	20
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults	20
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives	19
Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis	19
Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps	19
An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19	19
Next-generation sequencing reveals genetic heterogeneity in MEFV -negative or heterozygous familial Mediterranean fever: a retrospective study	18
T-lymphocyte depleted transplants for inborn errors of immunity	17
Inflammatory myopathy in adults, health-related quality of life, and wellbeing: a round trip between immune disease and wellness	17
Personalization of therapy for patients with eosinophilic esophagitis	17
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors	17
How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?	17
Eradicating measurable residual disease via immunotherapy to cure acute lymphoblastic leukemia: current status and future directions	16
The functional role and the clinical application of periostin in chronic rhinosinusitis	16
Pathophysiology and management of Staphylococcus aureus in nasal polyp disease	16
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia	16
Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management	15
Old and new autoantibodies in systemic lupus erythematosus	15
Recent insights into comorbidities in atopic dermatitis	15
Challenges in uncontrolled asthma in pediatrics: important considerations for the clinician	15
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity	15
The role of interleukins in pathogenesis and prognosis of atrial fibrillation	15
Advancements in immunotherapy for advanced esophageal squamous cell carcinoma: a comprehensive review of current strategies and future directions	15
The intratumor microbiome and cancer immunity: from pathogenesis to therapeutic opportunities through artificial intelligence	15
Chronic obstructive pulmonary disease, biological agents and small molecules: where do we stand?	15
IL-17A in psoriatic arthritis: mechanistic insights, clinical implications, and advances in therapeutic strategies	15
Temporal trends in anaphylaxis ED visits over the last decade and the effect of COVID-19 pandemic on these trends	14
Peanut allergy: risk factors, immune mechanisms, and best practices for oral immunotherapy success	14
Insights into the immunological links between dietary habits and asthma	14
Toward a personalized therapy of still’s disease based on immunologic endotypes: a narrative review	14
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation	14
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis	14
Translational approaches to childhood inflammatory brain diseases: a review	13
Updates in toxicities associated with immune checkpoint inhibitors	13
Induction of aquaporins by plasma of patients with systemic lupus erythematosus	13
At the cutting-edge: what’s the latest in imaging to diagnose Sjögren’s disease?	13
Advances in tumor immunotherapy targeting macrophages	13
Glucocorticoid in systemic lupus erythematosus: the art beyond science	13
What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?	13
Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency	13
Diagnostic accuracy of QuantiFERON-TB gold plus with chemiluminescence immunoassay: a systematic review and meta-analysis	13

New advances on the interaction between internal and external factors in the tumor microenvironment of solid tumors	13
The role of serological biomarkers in the diagnosis and management of autoimmune pancreatitis	13
Pediatric IgG4-related disease: a descriptive review	12
State of art and future challenges to early intervention, and management in patients with psoriasis at increased risk of transition to psoriatic arthritis: a review	12
Immunology and targeted therapy in Castleman disease	12
Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis – a meta-analysis of randomized clinical trials	12
The role of interleukin-15 in the spectrum of inflammatory diseases	12
Current approaches for diagnosis of subclinical pulmonary tuberculosis, clinical implications and future perspectives: a scoping review	12
Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts	12
How does sleep influence asthma through immunity?	12
Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics	11
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine	11
Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies	11
Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy	11
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases	11
The interaction between innate immunity and oral microbiota in oral diseases	11
Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis	11
Basophil activation test in the food allergy clinic: its current use and future applications	11
Guidance for stem cell therapy for juvenile systemic sclerosis patients	11
Individual differences in response to dust-mite-allergen specific immunotherapy in allergic rhinitis: a meta-analysis of randomized controlled trials	10
Transglutaminase 2 in chronic inflammation and fibrosis – a potential novel therapy for stricturing Crohn’s disease	10
Vascular endothelial dysfunction in pediatric rheumatic diseases: a systematic review and meta-analysis	10
Systemic therapy in juvenile localized scleroderma	10
B cell depletion and inhibition in systemic lupus erythematosus	10
A review of disease burden and clinical management for generalized pustular psoriasis in China	10
Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects	10
Update on virus-induced asthma exacerbations	10
An update on VEXAS syndrome	10
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications	10
Role of tight junction proteins in shaping the immune milieu of malignancies	10
Dysautonomia in systemic lupus erythematosus: when to suspect and how to investigate	10
Sequential immunotherapy for alopecia areata: phase-driven immune rebalancing	10
Potential approaches in repairing the damaged epithelial barrier in eosinophilic esophagitis	10
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience	10
An evaluation of anifrolumab for use in adults with systemic lupus erythematosus	10
Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies	10
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors	10
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation	10
The clinical role of anakinra in the armamentarium against familial Mediterranean fever	9
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons	9
Management and treatment optimization of patients with mild to moderate ulcerative colitis	9
Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective	9
Mechanisms and therapeutic potential of epithelial-immune crosstalk in airway inflammation	9
Biomarkers for systemic lupus erythematosus – a focus on organ damage	9
Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge	9
Interleukin-33/ST2 axis in Kawasaki disease: biology, vascular pathology, and future therapeutic strategies	9
The emerging role of IL-23 in asthma and its clinical implications	9
The relationship between interleukin 17A rs2275913 gene polymorphism and circulating IL17A levels and disease activity and severity in Egyptian rheumatoid arthritis patients	9
Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease	9
Considerations for managing elderly patients with atopic dermatitis	9
Asthma and neurodevelopmental and mental health disorder (NMD) multimorbidity in rural children	9
Clinical and immunologic implication of neo-osteogenesis in chronic rhinosinusitis	9
Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature	8
Development of a method of nasal secretions sampling for local nasal inflammation studies	8
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) in dermatology: cutaneous adverse events and emerging efficacy in inflammatory skin diseases	8
The clinical management of adult patients with Familial Mediterranean fever	8
Lack of association between TNFA and TNFB polymorphisms and the risk of multiple sclerosis: a meta-analysis from 37 studies	8
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults	8
Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options	8
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population	8
Potential interactions between STING pathway and the complement system in immune regulation	8
Rhupus syndrome: current knowledge and future perspectives	8
The burden of mental health issues in Behçet’s disease: implications for patient quality of life	8
Comorbid allergic rhinitis and asthma: important clinical considerations	8
The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review	8
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges	8
Toward precision in psoriatic arthritis: addressing the challenge of difficult-to-treat disease	8
A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease	8
Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an update	8
TBXAS1 deficiency: a novel monogenic cause of chronic nonbacterial osteomyelitis responsive to COX inhibitors	8
Cross-talk between immune cells and tumor cells in non-Hodgkin lymphomas arising in common variable immunodeficiency	8
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review	8
Revisiting an immunoneuropsychiatry classic: Sydenham’s chorea	8
Decoding T and B cell dynamics in inborn errors of immunity: insights into immune dysfunction	8
AQP9 weakens the cytotoxicity of CD8 + T cells in colon adenocarcinoma by boosting M2 polarization of macrophages under hypoxia conditions	8
The suitability of treating atopic dermatitis with Janus kinase inhibitors	8
Evaluating the role of lung ultrasound in the diagnosis of rheumatoid arthritis-interstitial lung disease	8
Response to letter to the editor: Bradford Hill and breast implant illness: evidence for a causal association with breast implants	8
Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patients	8
Inflammation resolution and specialized pro-resolving lipid mediators in chronic rhinosinusitis	7

Navigating obstetric antiphospholipid syndrome: pathophysiology, diagnosis, and therapeutic advances	7
Immunology of heart failure with preserved ejection fraction	7
Central nervous system immunological complications of immunotherapy in pediatrics	7
Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease	7
The relationship between MMP-2 and TIMP-2 gene polymorphisms and skin barrier function, inflammatory cytokine levels in acne patients	7
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis	7
IL-10: the master immunomodulatory cytokine in allergen immunotherapy	7
Thyroid eye disease in the biologic era: a 40-year paradigm shift in nonsurgical therapeutic strategies	7
What is the full potential of baricitinib in treating patients with COVID-19?	7
Genetic syndromes and autoimmunity: what do we know? Focus on Down and Turner syndrome	7
Telemedicine beyond the pandemic: challenges in the pediatric immunology clinic	7
Is post-COVID syndrome an autoimmune disease?	7
Unmet needs in the management of giant cell arteritis and polymyalgia rheumatica	7
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis	7
A new approach and conceptual model for understanding systemic sclerosis-associated gastrointestinal symptoms	7
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens	7
Managing acute COVID-19 in immunocompromised pediatric patients	7
The pathophysiology of MASLD: an immunometabolic perspective	7
Comparative efficacy of systemic treatments for atopic dermatitis in adults	7
COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?	7
Re-envisioning clinical trial design in systemic sclerosis	6
Nipocalimab for the treatment of moderate-to-severe Sjögren’s disease: a plain language summary of the DAHLIAS study	6
Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps	6
What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?	6
Clinical guide to eosinophilic fasciitis: straddling dermatology and rheumatology	6
Recent advances in the pathogenesis of neuropsychiatric systemic lupus erythematosus	6
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours	6
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus	6
Unmasking cancer’s silent saboteurs: T regulatory cells as therapeutic targets in immunotherapy	6
Should esophageal string test be used to monitor inflammation in EoE?	6
An evaluation of the recently approved drugs for treating atopic dermatitis in the context of their safety and efficacy: a systematic review and meta-analysis	6
The oft-overlooked cardiovascular complications of inflammatory bowel disease	6
Correction	6
Recent insights into the impacts of COVID-19 on pediatric asthma	6
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy	6
A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps	6
Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis	6
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease	6
Olfactory dysfunction in chronic rhinosinusitis: insights into the underlying mechanisms and treatments	6
Personalizing therapy selection in inflammatory bowel disease	6
Past, present and future of lupus nephritis	6
A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis	6
Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies – real-world data from the IG TATRY study	6
Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA)	5
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making	5
Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum aut	5
The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders	5
Update on the pathophysiology and treatment of diabetic kidney disease: a narrative review	5
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus	5
Neuro-ophthalmic challenges and multi-morbidity in vasculitis among the older adults	5
Exploring treatment options for pediatric refractory chronic urticaria	5
Avacopan for the treatment of ANCA-associated vasculitis: an update	5
A review of berotralstat for the treatment of hereditary angioedema	5
Comparing treatment options for large vessel vasculitis	5
Exploring the relationship between house dust mites and asthma	5
Correction	5
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy	5
Myocardial involvement in inflammatory myopathies: from subclinical disease to life-threatening myocarditis	5
Connecting salivary gland inflammation to specific symptoms in Sjögren’s disease	5
New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis	5
Diagnosis and management of systemic sclerosis-related calcinosis	5
Genes vs environment in inflammatory bowel disease: an update	5
Single-cell RNA sequencing: an emerging tool revealing dysregulated innate and adaptive immune response at single cell level in Kawasaki disease	5
Innovative surgical approaches for chronic rhinitis: nasal neurectomy mechanisms, techniques, and clinical outcomes	5
Probiotics in asthma management: fiction or truth?	5
Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition	5
Preventing fibrosis in IBD: update on immune pathways and clinical strategies	5
Biologics for chronic spontaneous urticaria: toward a personalized treatment	5
Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity	4
Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome	4
Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies	4
New therapeutic concepts against ischemia-reperfusion injury in organ transplantation	4
Anoikis and SPP1 in idiopathic pulmonary fibrosis: integrating bioinformatics, cell, and animal studies to explore prognostic biomarkers and PI3K/AKT signaling regulation	4
Management of severe asthma in children: current insights and future directions	4
TCF3 activates VEGFA transcription and reinforces PD-L1 expression in lung adenocarcinoma cells via NF-κB to attenuate the cytotoxicity of CD8 + T ce	4
Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients	4
Rationale for IL-37 as a novel therapeutic agent in inflammation	4
Autoimmune hemolytic anemia: causes and consequences	4
The relationship between bullous pemphigoid and renal disease and related treatments: a review of the current literature	4
Machine learning method for the cellular phenotyping of nasal polyps from multicentre tissue scans	4
Prognostic factors for post-operative outcomes in chronic rhinosinusitis with nasal polyps: a systematic review	4
Precision medicine in chronic rhinosinusitis – using endotype and endotype-driven therapeutic options	4
Mechanisms of resistance to adoptive cell therapy with tumor-infiltrating lymphocytes	4
Exploring allergy to novel foods in the Western countries: current and future perspectives	4
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives	4
Filgotinib in rheumatoid arthritis	4
How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?	4
Role of CD68 in the tumor immune microenvironment in Hodgkin’s lymphoma	4
The role of nasal cytology in the diagnosis and treatment of Allergic rhinitis	4
Pathophysiology of rejection in kidney transplantation	4
Behçet disease: epidemiology, classification criteria and treatment modalities	4
EVA1A facilitates glycolysis in esophageal squamous cell carcinoma to boost PLAU histone lactylation and dampen CD8 + T cell activity	4
Why do drug treatments fail in Sjögren’s disease? Considerations for treatment, trial design and interpretation of clinical efficacy	4
SLE criteria are by necessity still based on clinical (and immunological) criteria items	4
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma	4